- Home
- JCTC vs COCP Comparison
JCTC vs COCP Comparison
Compare JCTC & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCTC
- COCP
- Stock Information
- Founded
- JCTC 1953
- COCP 2006
- Country
- JCTC United States
- COCP United States
- Employees
- JCTC N/A
- COCP N/A
- Industry
- JCTC
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- JCTC
- COCP Health Care
- Exchange
- JCTC NYSE
- COCP Nasdaq
- Market Cap
- JCTC 13.2M
- COCP 15.4M
- IPO Year
- JCTC 1996
- COCP N/A
- Fundamental
- Price
- JCTC $3.49
- COCP $1.67
- Analyst Decision
- JCTC
- COCP Strong Buy
- Analyst Count
- JCTC 0
- COCP 1
- Target Price
- JCTC N/A
- COCP $6.00
- AVG Volume (30 Days)
- JCTC 16.7K
- COCP 26.1K
- Earning Date
- JCTC 07-14-2025
- COCP 08-13-2025
- Dividend Yield
- JCTC N/A
- COCP N/A
- EPS Growth
- JCTC N/A
- COCP N/A
- EPS
- JCTC N/A
- COCP N/A
- Revenue
- JCTC $44,141,421.00
- COCP N/A
- Revenue This Year
- JCTC N/A
- COCP N/A
- Revenue Next Year
- JCTC N/A
- COCP N/A
- P/E Ratio
- JCTC N/A
- COCP N/A
- Revenue Growth
- JCTC N/A
- COCP N/A
- 52 Week Low
- JCTC $3.26
- COCP $1.12
- 52 Week High
- JCTC $5.41
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- JCTC N/A
- COCP 53.98
- Support Level
- JCTC N/A
- COCP $1.59
- Resistance Level
- JCTC N/A
- COCP $1.76
- Average True Range (ATR)
- JCTC 0.00
- COCP 0.14
- MACD
- JCTC 0.00
- COCP 0.00
- Stochastic Oscillator
- JCTC 0.00
- COCP 28.18
About JCTC JEWETT-CAMERON TRADING CO
Jewett-Cameron Trading Co Ltd through its subsidiaries engages in the wholesale distribution of a variety of specialty wood products. Its operating segments include, The Industrial wood products segment is engaged in the processing and distribution of industrial wood products. The Pet Fencing and Other segment, which is the key revenue driver, operates as a wholesaler of wood products and a manufacturer and distributor of specialty metal products. The Seed processing and sales segment processes and distributes agricultural seed and Corporate and administrative. The company predominantly operates in the United States and also has a presence in Canada, Latin America, Europe and Asia Pacific, and other regions.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).